The Heart of the Matter in the Fight Against AIDS, Tuberculosis and Malaria

The last century brought with it a landslide of medical breakthroughs, from penicillin to a polio vaccine. But scientific discovery is just the first step. Only when these tools move out of the laboratory and into the hands of people do we begin to feel their transformative impact.
This post was published on the now-closed HuffPost Contributor platform. Contributors control their own work and posted freely to our site. If you need to flag this entry as abusive, send us an email.

The last century brought with it a landslide of medical breakthroughs, from penicillin to a polio vaccine. But scientific discovery is just the first step. Only when these tools move out of the laboratory and into the hands of people do we begin to feel their transformative impact.

In the late 1990s, new antiretroviral therapy promised hope in the fight against HIV/AIDS. Access to the drugs was suddenly turning the modern plague into a treatable condition. Yet despite its lifesaving power, the expensive treatment was out of reach for much of the world's population, which meant HIV remained a death sentence for millions.

International leaders fomented change in 2002. UN Secretary General Kofi Annan called for action. The United States under President Bush created an Emergency Plan for AIDS Relief (PEPFAR). And, collectively, the world created the Global Fund to Fight AIDS, Tuberculosis and Malaria. This public-private partnership and financing institution set out to support treatment, prevention and care for HIV/AIDS, as well as the other two deadly diseases, in hard hit communities worldwide.

Since 2002, working closely with local partners and other donors--including the United States' PEPFAR and President's Malaria Initiative programs--the Global Fund has helped save millions of lives. In a little over a decade, HIV/AIDS treatment has increased more than twenty-fold, malaria cases have fallen by half, and deaths from tuberculosis have decreased dramatically.

We stand now, though, on the cusp of yet another breakthrough in getting medical tools to fight AIDS, tuberculosis and malaria into the hands of those who most need them. Ten years of epidemiological and implementation experience has shown us that some of the populations that are hardest to reach because of geography, stigma or criminalization are also often at the highest risk for communicable disease.

To truly bring the three diseases under control, a successful strategy requires that marginalized groups receive the public health attention they need--and are treated with the dignity they deserve. Focusing on these groups is not only the right thing to do, it's also the medically smart thing to do.

The Global Fund has financed health interventions for those facing the greatest need and the greatest risks since its inception. The organization prioritizes support for marginalized populations--the geographically isolated, women and girls, men who have sex with men, commercial sex workers, migrants and others.

Through the "country dialogue" process at the center of its new grant making structure, the Global Fund is attempting to bring more parties to the table, to ensure that no one is left behind. And today the Global Fund is even better incorporating human rights concerns into its work, with enhanced tracking of support for vulnerable populations, improved training for grant managers, and a new human rights reference group.

By targeting high-risk populations and using the latest scientific knowledge, the Global Fund is evolving to ensure its investments help reduce transmission and save even more lives. This work isn't easy. It depends on local community groups, faith-based organizations and people affected by the three diseases, who can help make sure Global Fund resources get to where they're needed most.

The Global Fund is also preparing for the next three years of expanded work against HIV/AIDS, tuberculosis and malaria. In just a few months, the organization will bring together international donors, inviting them to make multiyear commitments to fight these epidemics.

This fight won't be finished until access to lifesaving treatment, prevention and care is no longer determined by who people are or where they live. By investing now, we have the chance to be the generation that defeats these three diseases. There is still a long road ahead, but step-by-step we are headed in the right direction.

This post is part of a series produced by The Huffington Post and the NGO alliance InterAction around the United Nations General Assembly's 68th session and its general debate on the Millennium Development Goals (MDGs), "Post-2015 Development Agenda: Setting the Stage" (September 24-October 2, 2013). The session will feature world leaders discussing progress made on the MDGs and what should replace them when they expire in 2015. To read all the posts in the series, click here; to follow the conversation on Twitter, find the hashtag #No1Behind. For more information about InterAction, click here.

Popular in the Community

Close

What's Hot